Skip to main content
Tech.euFundingExplorerBeta

Rejuvenate Boimed

Rejuvenate Biomed is a science based healthy aging company developing prescription drugs in healthy aging by repositioning approved drugs.

Total raised
€16M
€15,700,000
Funding rounds
1
Investors
2
distinct backers
Active since
2021-10
latest 2021-10

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood18
base rate 48% for Series B
  • Dormant (no round in 3+ cohort gaps)
  • Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2021-10-12Series B€16MRejuveron,Vesalius Biocapital PartnersView deal →

Related news

Similar companies

same sector or country